CXCL8 signaling is a major pro-inflammatory signal in multiple solid tumors including breast and colorectal cancers [23], [24], diseases in which 5-FU is currently used or recommended as standard-of-care for metastatic disease. This evidence concerns the gene CXCL8 and colorectal cancer.